logo
Select company
Select metric
$ -3.86EBITDA per Share
VS
Market
7
Sector
16
Industry
20
History
40
$ 11.01Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -82.41M$ -3.86121.38M
3/31/2025$ -87.12M$ -4.08121.36M
12/31/2024$ -94.42M$ -4.45121.24M
9/30/2024$ -104.51M$ -4.94121.16M
6/30/2024$ -104.08M$ -4.91121.18M
3/31/2024$ -116.17M$ -5.49121.17M
12/31/2023$ -124.91M$ -5.92121.09M
9/30/2023$ -123.48M$ -5.89120.97M
6/30/2023$ -123.46M$ -5.86121.05M
3/31/2023$ -122.69M$ -5.83121.04M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.57.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average EBITDAPS has been $ -4.95.
  • The median EBITDAPS for ENANTA PHARMACEUTICALS INC during this period was $ -5.33
  • ENANTA PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -1.57.
  • The lowest EBITDAPS recorded by ENANTA PHARMACEUTICALS INC in the same timeframe $ -6.2

ENANTA PHARMACEUTICALS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
THTX : THERATECHNOLOGIES INC $ 0.16BDTX : BLACK DIAMOND THERAPEUTICS INC $ 0.26PLX : PROTALIX BIOTHERAPEUTICS INC $ 0.13ALEC : ALECTOR INC $ -1.06SGMO : SANGAMO THERAPEUTICS INC $ -0.22CSBR : CHAMPIONS ONCOLOGY INC $ 0.32SPRO : SPERO THERAPEUTICS INC $ -0.96CCCC : C4 THERAPEUTICS INC $ -1.45TRDA : ENTRADA THERAPEUTICS INC $ -1.77CELU : CELULARITY INC $ -2.42

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for ENANTA PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -31.38M ] / (Shares WA [ 19.94M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.57 ]

ENTA - EBITDA per Share, Last 5 years

$ -6.2

Minimum

Mar 31, 2022

$ -1.57

Maximum

Sep 30, 2020

$ -4.95

Average

$ -5.33

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26